Roche names Wafaa Mamilli as Chief Digital Technology Officer

Published On 2025-01-31 08:00 GMT   |   Update On 2025-01-31 08:00 GMT

Basel: Roche has announced that Wafaa Mamilli will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas Schinecker, and will become a member of the enlarged Corporate Executive Committee starting 10 February 2025. She will be based at Genentech in South San Francisco.

In this new role, she will take over the worldwide responsibility for the Informatics function for the Roche Group from Alan Hippe, who currently has the dual role of Chief Financial Officer (CFO) and Chief Informatics Officer (CIO).

"With our ambitions to transform our business with digital solutions and through enterprise-wide use of artificial intelligence, this is the right moment to split the two roles and ensure dedicated focus – Alan Hippe as CFO and Wafaa Mamilli as CDTO," the release stated.

Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis. Prior to joining Zoetis in 2020, Ms. Mamilli spent over 20 years with Eli Lilly and Company, where she held various international roles with increasing responsibility and ultimately served as the global chief information officer for the company’s business units.

She earned a master’s degree in computer science from INSEA in Rabat, Morocco, a master’s degree in business applications of information and technology from Université Rennes in Rennes, France, and completed the Advanced Management Program at Harvard Business School. She also serves on the board of directors of Fiserv.

Roche’s CEO Thomas Schinecker: “With the speed of technology and its strategic importance to our business now and for the future, I am thrilled to have Wafaa Mamilli joining us. She is a visionary leader with deep technical and business expertise who will be instrumental in leveraging the power of digitalization and artificial intelligence across our business.”

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News